Company Filing History:
Years Active: 2022
Title: Linda Hibbert: Innovator in Immunotherapy
Introduction
Linda Hibbert is a prominent inventor based in Abingdon, GB. She has made significant contributions to the field of immunotherapy, particularly through her work on T cell receptors. Her innovative approach aims to enhance the treatment of malignant diseases.
Latest Patents
Linda Hibbert holds a patent related to T cell receptors (TCRs) that bind the HLA-A*02 restricted peptide GVYDGREHTV. This invention focuses on TCRs derived from the germline cancer antigen MAGE A4. The TCRs may include non-natural mutations within the alpha and/or beta variable domains compared to a native MAGE A4 TCR. These TCRs are particularly suitable for use as novel immunotherapeutic reagents for treating malignant diseases. She has 1 patent to her name.
Career Highlights
Linda is associated with Immunocore Limited, a company dedicated to advancing immunotherapy solutions. Her work has positioned her as a key player in the development of innovative treatments for cancer.
Collaborations
Linda collaborates with notable colleagues, including Conor Hayes and Nathaniel Ross Liddy. Their combined expertise contributes to the advancement of immunotherapeutic research.
Conclusion
Linda Hibbert's contributions to the field of immunotherapy through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for new treatment options in the fight against cancer.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.